Men With ED: 25% Are Aged 40 Years or Younger

Traditionally considered the bane of aging men, erectile dysfunction (ED) is surprisingly common in younger men as well, the authors of a new study report.

Of 439 men visiting a sexual medicine outpatient clinic complaining of new-onset ED, 114 (26%) were 40 years old or younger, lead author Paolo Capogrosso, MD, from the Department of Urology, University Vita-Salute San Raffaele, Milan, Italy, and colleagues write in an article published online May 7 in the Journal of Sexual Medicine.

Moreover, the rate of severe ED was similar in younger and older men, and scores on the International Index of Erectile Function (IIEF) also were similar between the age groups. "Therefore, the observation as a whole appeared to us as a worrisome picture from the everyday clinical practice," the authors write.

Read the full Medscape Medical News report
(Free sign-up may be required)

Heart-Healthy Diet May Be Prostate Cancer Healthy Too

UPDATED June 13, 2013 — A diet that reduces carbohydrates and animal fat intake and boosts vegetable fat consumption could benefit men with prostate cancer, a new observational study concludes.
This dietary-fat mix mirrors a heart-healthy diet and was associated with better overall and prostate-cancer-related mortality in a large cohort of men, report the authors, led by Erin Richman, ScD, from the Department of Epidemiology and Biostatistics at the University of California, San Francisco.

"Overall, our findings support counseling men with prostate cancer to follow a heart-healthy diet in which carbohydrate calories are replaced with unsaturated oils and nuts to reduce the risk of all-cause mortality," write the authors.

Nuts and vegetable oils (such olive and canola oil) were the 2 sources of vegetable fats associated with reduced overall and disease-specific mortality.

Read the full Medscape report
(Free sign-up may be required)

Pomegranate and other Extracts for Prostate Cancer - Should You Take Them ?

A recent well done studied found that an extract of pomegranate seeds, broccoli, green tea and Turmeric reduced the number of men with a rising PSA and more often reduced the PSA at 6 months compared to a placebo. The video explains the results and what it means for patients with prostate cancer

Food Supplement Linked to Lower PSA in Prostate Cancer

CHICAGO, Illinois — A commercially available food supplement that contains pomegranate, broccoli, green tea, and turmeric significantly lowers prostate-specific antigen (PSA) levels, compared with placebo, in patients with prostate cancer, a double-blind placebo-controlled randomized trial has shown.
The study results, presented here at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO^®), made headlines around the world and caused the polyphenol-rich supplement, known as Pomi-T (nature Medical Products), to sell out within hours.

This is a "promising new therapy," said Tomasz Beer, MD, professor of medicine and director of the prostate cancer research program at the Oregon Health and Science University in Portland, during a "highlights of the day" session.

Read the full Medscape report
(Free sign-up may be required)

Vegetable fats tied to less prostate cancer spread

(Reuters Health) - After being diagnosed with prostate cancer, men who eat a diet high in vegetable fats, such as those in nuts and olive oil, may be less likely to have their disease spread, a new study suggests.

Researchers found that replacing some carbohydrates with those healthy fats was also tied to a lower risk of dying from any cause during the study. But the opposite was true for saturated and trans fats often found in meat and processed foods.

Read the full Reuters Health report

Agent Orange tied to aggressive prostate cancer risk

(Reuters Health) - Men who were exposed to Agent Orange chemicals used during the Vietnam War are at higher risk for life-threatening prostate cancer than unexposed veterans, researchers have found.


What's more, those who served where the herbicide was used were diagnosed with cancer about five years earlier than other men, on average, in the new study.

"This is a very, very strong predictor of lethal cancer," said urologist Dr. Mark Garzotto, who worked on the study at the Portland Veterans Affairs Medical Center in Oregon.

Read the full Reuters Health report

Gene Test for Prostate Cancer Shows Promise

Medscape. May 08, 2013

SAN DIEGO, California — A genetic test can predict the aggressiveness of prostate cancer, a new study shows.
The 17-gene test predicts whether tumors will progress to high-grade or postsurgical stage III disease.

"We think this will allow patients and doctors to make more confident decisions," study coauthor Eric Klein, MD, told Medscape Medical News. "That will be a boon to everyone and it will save the system money."

The results of the study were presented here at the American Urological Association 2013 Annual Scientific Meeting.

Read the full Medscape report
(Free sign-up may be required)